Continuous veno-venous hemofiltration with regional citrate anticoagulation: A four-year single-center experience

International Journal of Artificial Organs

Volumn 31, Issue 11, 2008, Pages 937-943

  Cassina, Tiziano ^a   Mauri, R ^a   Engeler, A ^a   Giannini, O ^b  

^a DIVISION OF CARDIOLOGY   (Switzerland)

^b Ospedale Beata Vergine   (Switzerland)

Author keywords

Acute kidney injury; Bleeding complications; Cardiac surgery; Citrate anticoagulation; Hemofiltration

Indexed keywords

BLOOD; CALCIUM CHLORIDE; ELECTROLYTES; INTENSIVE CARE UNITS; METABOLISM; UREA;

ACID BASE; ACUTE KIDNEY INJURY; ANTI-COAGULATION; BLEEDING COMPLICATION; BLEEDINGS; BUFFER EFFECT; CARDIAC-SURGERY; CITRATE ANTICOAGULATION; CLINICAL PRACTICES; HEMOFILTRATION;

IONIZATION;

ALBUMIN; CALCIUM CHLORIDE; CALCIUM ION; CITRIC ACID; ELECTROLYTE; UREA;

ACID BASE BALANCE; AGED; ANTICOAGULATION; ARTICLE; CALCIUM BLOOD LEVEL; CONTINOUS VENOVENOUS HEMOFILTRATION; CONTROLLED STUDY; ERYTHROCYTE CONCENTRATE; EXTRACORPOREAL CIRCULATION; FEMALE; FILTER; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; MORTALITY; RENAL REPLACEMENT THERAPY; UREA NITROGEN BLOOD LEVEL;

EID: 59549106233     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803101103     Document Type: Article

References (27)

1. Palomba H, de Castro I, Neto ALC, Lage S, Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int 2007; 72: 624-31.
2. Gummert JF, Bucerius J, Walther T, et al. Requirement for renal replacement therapy in patients undergoing cardiac surgery. Thorac Cardiovasc Surg 2004; 52: 70-6.
3. Van de Wetering J, Westendorp RGJ, Van der Hoeven JG, et al. Heparin use in continuous renal replacement procedures: the struggle between filter coagulation and patient hemorrhage. J Am Soc Nephrol 1996; 7: 145-50.
4. Ward DM, Mehta RL. Extracorporeal management of acute renal failure patients at high risk of bleeding. Kidney Int Suppl 1993; 41: S237-44.
5. Calatzis A, Toepfer M, Schramm W, Spannagl M, Schiffl H. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 2001; 89: 233-6.
6. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999; 55: 1991-7.
7. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, ADQI workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12.
8. Hofmann RM, Maloney C, Ward DM, Becker BN. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Ren Fail 2002; 24, 3: 325-35.
9. Kutsogiannis DJ, Mayers I, Chin WDNC, Noel Gibney RT. Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration. Am J Kidney Dis 2000; 35: 802-11.
10. Cole L, Bellomo R, Baldwin R, Hayhoe M, Ronco C. The impact of lactate-buffered high-volume hemofiltration on acid-base balance. Intensive Care Med 2003; 29:1113-1120.
11. Bellomo R, Naka T, Baldwin I. Intravenous fluid and acid-base balance. In: Ronco C (ed). Sepsis, Kidney and Multiple Organ Dysfunction. Basel, Switzerland: Karger; 2004. p 105-118.
12. Owen W F, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-6.
13. Cointault O, Kamar N, Bories P, et al. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions. Nephrol Dial Transplant 2004; 19: 171-8.
14. Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS. Regional hemodialysis anticoagulation: Hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A. Am J Kidney Dis 1996; 27: 519-24.
15. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356; 26-30.
16. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001; 60: 370-4.
17. Fischer KG, Van de Loo A, Böhler J. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis. Kidney Int 1999; 56: 46-50.
18. Reeves J, Cumming A, Gallagher L, O'Brien J, Santamaria J. A controlled trial of low-molecular weight heparin(deltaparin) versus unfractionated heparin as anticoagulant during venovenous hemodialys with filtration. Crit Care Med 1999; 27: 2224-8.
19. Tan HK, Baldwin L, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000; 26: 1652-7.
20. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Continuous venovenous hemofiltration without anticoagulation. ASAIO J 2004; 50: 76-80.
21. Kaplan AA, Petrillo R. Regional heparinisation for continous arteriovenous hemofiltration. ASAIO Trans 1987; 33: 312-5.
22. Kozek-Langenecker SA, Kettner SC, Oismueller C, et al. Anticoagulation with prostaglandin E1 and unfractionated heparin during continuous venovenous hemofiltration. Crit Care Med 1998; 26:1208-12.
23. Mehta RL, McDonald B, Aguilar M, Ward D. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38: 976-81.
24. Thoenen M, Schmid ER, Binswanger U, et al. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Wien Klin Wochenscht 2002; 114/3: 108-14.
25. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C. Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 2002; 28: 1419-25.
26. Bihorac A, Ross EA. Continuous venovenous Hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Am J Kidney Dis 2005; 46: 908-18.
27. Monchi M, Berghmans D, Ledoux D, Canivet J, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 2004; 30: 260-5.